Detalhe da pesquisa
1.
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.
Immunity
; 55(7): 1316-1326.e4, 2022 07 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35690062
2.
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.
Nature
; 602(7898): 654-656, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35016196
3.
Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency.
PLoS Pathog
; 19(11): e1011755, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-38032851
4.
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.
Proc Natl Acad Sci U S A
; 118(19)2021 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33893175
5.
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection.
Emerg Infect Dis
; 29(2): 381-388, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36692375
6.
Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data.
Malar J
; 22(1): 42, 2023 Feb 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36737743
7.
Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design.
J Infect Dis
; 226(2): 236-245, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35104873
8.
Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial.
Clin Infect Dis
; 75(1): e878-e879, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35100611
9.
Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice.
Malar J
; 21(1): 49, 2022 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35172826
10.
Within-host modeling of blood-stage malaria.
Immunol Rev
; 285(1): 168-193, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30129195
11.
Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cells.
PLoS Pathog
; 15(2): e1007599, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30811498
12.
HIV Reactivation after Partial Protection by Neutralizing Antibodies.
Trends Immunol
; 39(5): 359-366, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29366547
13.
Impact of fluctuation in frequency of human immunodeficiency virus/simian immunodeficiency virus reactivation during antiretroviral therapy interruption.
Proc Biol Sci
; 287(1933): 20200354, 2020 08 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32811309
14.
Host-mediated impairment of parasite maturation during blood-stage Plasmodium infection.
Proc Natl Acad Sci U S A
; 114(29): 7701-7706, 2017 07 18.
Artigo
Inglês
| MEDLINE | ID: mdl-28673996
15.
Estimating Initial Viral Levels during Simian Immunodeficiency Virus/Human Immunodeficiency Virus Reactivation from Latency.
J Virol
; 92(2)2018 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29118123
16.
In Silico Investigation of the Decline in Clinical Efficacy of Artemisinin Combination Therapies Due to Increasing Artemisinin and Partner Drug Resistance.
Antimicrob Agents Chemother
; 62(12)2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30249691
17.
Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?
J Virol
; 91(24)2017 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29021399
18.
Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission.
PLoS Pathog
; 12(8): e1005745, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27561082
19.
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission.
PLoS Pathog
; 11(7): e1005000, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26133551
20.
A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection.
J Theor Biol
; 430: 117-127, 2017 10 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28728995